Dan Betensky

[Mass General Brigham Research @MGBResearchNews]

In a new study, researchers from @BrighamWomens found that GLP-1 drugs were shown to be cost-effective for knee osteoarthritis and obesity. The study was published in @AnnalsofIM.

Read more: https://t.co/1ZtoZ41tjC

[Annals of Int Med @AnnalsofIM]

New this week: Adding the #GLP1 drugs #semaglutide and tirzepatide to usual care could be a cost-effective treatment strategy for people with knee #osteoarthritis and obesity. https://t.co/LLdtsqYHsn @MGBResearchNews @BrighamWomens

[OrACORe @OrACORe_BWH]

New from OrACORe!
Former RA Dan Betensky is first author on a study in Annals of Internal Medicine showing GLP-1s are cost-effective for knee OA + obesity

Check it out here!
https://t.co/0TOeQGLYbP

[Jayasuriya Lab @JayasuriyaLab]

Check out our new study in @JOrthopRes led by @danbet17 which demonstrates that EVs from cartilage progenitors stimulate ECM anabolism and wound healing activity in human meniscal fibrochondrocytes.
@OrsMeniscus @ORSsociety

https://t.co/UiFnKEWeW4